Literature DB >> 82854

Controlled clinical trials and medical ethics.

R Burkhardt, G Kienle.   

Abstract

During the past 5 years, a great deal of public attention has been paid in the Federal Republic of Germany to legal and ethical implications of controlled clinical trials. If a physician is bound by a contract for treatment, the ethics of individual benefit have to be applied and this might inhibit a controlled trial. To avoid ethical and legal difficulties, a contract for experimentation may have to be introduced.

Entities:  

Mesh:

Year:  1978        PMID: 82854

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  Ethics of clinical trials -- the use of placebo.

Authors:  L Wilhelmsen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

2.  Controlled trials - a social challenge. Comments on a recent controversy.

Authors:  R Burkhardt; G Kienle
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  [Controversial viewpoints on the use of historical controls: Is there an all-or-nothing law?].

Authors:  G Feifel
Journal:  Langenbecks Arch Chir       Date:  1981

4.  Significance of controlled clinical trials.

Authors:  A Liljestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

5.  Histamine and stress ulcer: new components in organizing a sequential trial on cimetidine prophylaxis in seriously ill patients and definition of a special group at risk (severe polytrauma).

Authors:  W Lorenz; M Fischer; H Rohde; H Troidl; H J Reimann; C Ohmann
Journal:  Klin Wochenschr       Date:  1980-07-01

6.  The scientific and ethical basis of the clinical evaluation of medicines. Report of an international conference, held as a guest conference at the Ditchley Foundations, Ditchley Park, England, 13-16 September 1979.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

7.  Placebos and controlled trials under attack.

Authors:  L Lasagna
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.